Notably, miR-128-3p antagonism profoundly affects metastasis and chemoresistance in aggressive phenotype NSCLC cells, which can be entirely reversed by restoring Wnt/β-catenin and TGFβ-activities, revealing that miR-128-3p might be a candidate for both tumor growth and chemoresistance in NSCLC (69b). Here, TGFB1 is linked to non-small cell lung carcinoma.